Japanese Companies Create Joint Venture To Develop Drug Generics
This article was originally published in PharmAsia News
Executive Summary
Japanese firms Seven & i Holdings and Ain Phamaciez have agreed to establish a separate company in late May to develop generic drugs. Seven & i, which seeks to use the government's new emphasis on generics to expand its drug business, is to have a 10 percent stake and other firms in its group that operate drug stores is to own another 60 percent, with the remaining 30 percent to be owned by Ain. (Click here for more - a subscription may be required